Annual Drug Patent Expirations for TWIRLA
Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this drug.
This drug has fifty-six patent family members in twenty-three countries.
The generic ingredient in TWIRLA is ethinyl estradiol; levonorgestrel. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
